Aethlon Medical, Inc

32 articles about Aethlon Medical, Inc

• Aethlon Medical Announces Fiscal Third Quarter 2023 Financial Results and Provides Corporate Update

  2/14/2024

  Aethlon Medical, Inc. reported financial results for its fiscal third quarter ended December 31, 2023 and provided an update on recent developments.

• Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

  2/7/2024

  Aethlon Medical, Inc. today announced that it will issue financial results for its fiscal third quarter ended December 31, 2023 , at 4:15 p.m. ET on Wednesday, February 14, 2024 .

• Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update

  11/14/2023

  Aethlon Medical, Inc. reported financial results for its fiscal second quarter ended September 30, 2023 and provided an update on recent developments.

• Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer

  11/13/2023

  Aethlon Medical, Inc. today announced that James B. Frakes , M.B.A., Chief Financial Officer of the Company, was appointed as Interim Chief Executive Officer, replacing Charles J. Fisher, Jr. M.D.

• Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

  11/6/2023

  Aethlon Medical, Inc. today announced that it will issue financial results for its second quarter ended September 30, 2023, at 4:15 p.m. ET on Tuesday, November 14, 2023.

• Aethlon Announces Reverse Stock Split - October 04, 2023

  10/4/2023

  Aethlon Medical, Inc. announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company's common stock, effective at 5:00 p.m. ET on October 4, 2023.

• Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference

  8/30/2023

  Aethlon Medical, Inc. announced that Steven LaRosa, M.D., Chief Medical Officer, and James Frakes, Chief Financial Officer, will present a company overview on Tuesday, September 12 at 4:30 PM EST, during the H.C. Wainwright 25th Annual Global Investment Conference taking place September 11-13, 2023, in New York City.

• Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update - August 10, 2023

  8/10/2023

  Aethlon Medical, Inc., a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, reported financial results for its fiscal first quarter ended June 30, 2023 and provided an update on recent developments.

• Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023

  8/3/2023

  Aethlon Medical, Inc. announced that it will issue financial results for its first quarter ended June 30, 2023, at 4:15 p.m. EST on Thursday, August 10, 2023.

• Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant

  7/24/2023

  Aethlon Medical, Inc. announced that it has signed a Collaboration Agreement with 34 Lives, PBC, to investigate the use of Aethlon's proprietary Hemopurifier® technology and 34 Lives' organ evaluation and preservation system, with the goal of increasing the supply of useable donated kidneys for human transplant.

• Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update - June 28, 2023

  6/28/2023

  Aethlon Medical, Inc., a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, reported financial results for its fiscal year ended March 31, 2023 and provided an update on recent developments.

• Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023

  6/22/2023

  Aethlon Medical, Inc. today announced that it will issue financial results for its fourth quarter ended March 31, 2023 , at 4:15 p.m. EST on Wednesday , June 28, 2023.

• Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation

  6/21/2023

  Aethlon Medical, Inc., a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, announced that it is investigating the use of its Hemopurifier® in the organ transplant market, in addition to its ongoing studies in cancer and COVID-19.

• Aethlon Medical to Present at the 13th Annual LD Micro Invitational

  6/1/2023

  Aethlon Medical, Inc. announced that Guy Cipriani, Senior Vice President and Chief Business Officer, and James Frakes, Chief Financial Officer, will present a company overview at the 13th Annual LD Micro Invitational on Wednesday, June 7, 2023, at 1:30 PM PT.

• Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India

  5/22/2023

  Aethlon Medical, Inc. announced that it has received Ethics Review Board approval from the Maulana Azad Medical College, for a second site for its ongoing clinical trial of Aethlon's Hemopurifier® to treat severe COVID-19 in India.

• Aethlon Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

  2/13/2023

  Aethlon Medical, Inc. reported financial results for its third quarter ended December 31, 2022 and provided an update on recent developments.

• Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023

  2/6/2023

  Aethlon Medical, Inc. (NASDAQ: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its third quarter ended December 31, 2022, at 4:15 p.m. EST on Monday, February 6, 2023.

• Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023

  1/31/2023

  Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease,  announced today that it will be presenting virtually at the upcoming Sequire Biotechnology Conference on Thursday, February 2nd, at 10:00 AM ET.

• Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer

  1/30/2023

  Aethlon Medical, Inc. today announced that it has entered into an agreement with NAMSA.

• Aethlon Medical to Present at Two Investor Conferences in September 2022

  9/6/2022

  Aethlon Medical, Inc., a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, announced that it will be presenting at two investor conferences in September.